Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
, 10 (3), 188-95

Impact of High-Throughput Screening in Biomedical Research

Affiliations
Review

Impact of High-Throughput Screening in Biomedical Research

Ricardo Macarron et al. Nat Rev Drug Discov.

Abstract

High-throughput screening (HTS) has been postulated in several quarters to be a contributory factor to the decline in productivity in the pharmaceutical industry. Moreover, it has been blamed for stifling the creativity that drug discovery demands. In this article, we aim to dispel these myths and present the case for the use of HTS as part of a proven scientific tool kit, the wider use of which is essential for the discovery of new chemotypes.

Similar articles

See all similar articles

Cited by 192 PubMed Central articles

See all "Cited by" articles

References

    1. Drug Discov Today. 2003 Aug 1;8(15):655-6 - PubMed
    1. Curr Opin Chem Biol. 2010 Jun;14(3):289-98 - PubMed
    1. Expert Opin Drug Discov. 2007 May;2(5):603-19 - PubMed
    1. Nat Rev Drug Discov. 2009 Dec;8(12 ):959-68 - PubMed
    1. Assay Drug Dev Technol. 2005 Feb;3(1):17-26 - PubMed

Substances

LinkOut - more resources

Feedback